ORIGINAL RESEARCH
Published on 16 May 2025
Effect of bispecific recombinant oncolytic adenovirus carrying apoptin on apoptosis of MCF-7 cells
doi 10.3389/fimmu.2025.1530583
- 458 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Unveiling the Next Generation of Cancer Immunity & Immunotherapy
Unveiling the Next Generation of Cancer Immunity & Immunotherapy
8,619
Total downloads
33k
Total views and downloads
Articles
REVIEW
Published on 17 Apr 2025
Revisiting the role of cancer-associated fibroblasts in tumor microenvironment
doi 10.3389/fimmu.2025.1582532
- 1,164 views
REVIEW
Published on 11 Apr 2025
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy
doi 10.3389/fimmu.2025.1562797
- 1,094 views
REVIEW
Published on 19 Feb 2025
Expanding the horizon of CAR T cell therapy: from cancer treatment to autoimmune diseases and beyond
doi 10.3389/fimmu.2025.1544532
- 2,709 views
REVIEW
Published on 25 Nov 2024
B7-H3 in glioblastoma and beyond: significance and therapeutic strategies
doi 10.3389/fimmu.2024.1495283
- 3,314 views
- 1 citation
ORIGINAL RESEARCH
Published on 21 Nov 2024
Global trends and research hotspots in perioperative management of lung cancer: a bibliometric analysis from 2004 to 2024
doi 10.3389/fimmu.2024.1500686
- 1,398 views
ORIGINAL RESEARCH
Published on 20 Nov 2024
Discovery and preclinical evaluation of BPB-101: a novel triple functional bispecific antibody targeting GARP-TGF-β complex/SLC, free TGF-β and PD-L1
doi 10.3389/fimmu.2024.1479399
- 1,348 views
- 1 citation
CASE REPORT
Published on 01 Nov 2024
Local radiotherapy in extensive-stage small-cell lung cancer sustainably boosts the clinical benefit of first-line immunotherapy: a case report
doi 10.3389/fimmu.2024.1493740
- 4,058 views
- 1 citation
REVIEW
Published on 30 Oct 2024
Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients
doi 10.3389/fimmu.2024.1483806
- 2,025 views
- 1 citation
ORIGINAL RESEARCH
Published on 19 Sep 2024
High specificity of engineered T cells with third generation CAR (CD28-4-1BB-CD3-ζ) based on biotin-bound monomeric streptavidin for potential tumor immunotherapy
doi 10.3389/fimmu.2024.1448752
- 1,855 views
REVIEW
Published on 30 Aug 2024
Unlocking the potential of iPSC-derived immune cells: engineering iNK and iT cells for cutting-edge immunotherapy
doi 10.3389/fimmu.2024.1457629
- 4,235 views
- 2 citations
PERSPECTIVE
Published on 26 Aug 2024
Intratumoral injection and retention hold promise to improve cytokine therapies for cancer
doi 10.3389/fonc.2024.1456658
- 1,691 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore